YieldMax MRNA Option Income Strategy ETF (NYSEARCA:MRNY) declares $0.0221/share weekly dividend. Payable Oct. 17; for shareholders of record Oct. 16; ex-div Oct. 16. See MRNY Dividend Scorecard, Yield ...

Moderna (MRNA) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...

Moderna is expected to announce its third-quarter results next month, and analysts expect a significant loss per share.

In earlier laboratory experiments, researchers had observed that mRNA vaccines improve the effectiveness of cancer drugs such ...

The federal government is cutting $500 million in research money for development of mRNA vaccines, which were widely used against the COVID-19 virus. Health Secretary Robert F. Kennedy Jr. said in a ...

Vaccines using mRNA technology weren’t immune to the latest round of federal research cuts. Health and Human Services Secretary Robert F. Kennedy Jr. said this week that he’s pulling the plug on ...

RNA came to prominence during COVID-19 with mRNA vaccines saving millions of lives worldwide. Since then, the technology has evolved with some developers now focusing on personalized mRNA therapeutics ...

Although mRNA vaccines saved millions of lives during the COVID-19 pandemic, U.S. Health Secretary Robert F. Kennedy Jr. incorrectly argued they are ineffective to justify the Department of Health and ...

Researchers at Harvard Medical School and Brigham and Women's Hospital designed an ingestible capsule that delivers liquid mRNA to the intestines, producing gene expression and reducing inflammation ...

In his first 6 months as HHS secretary, Robert F. Kennedy Jr. has looked on as the FDA approved three mRNA-based vaccines: expanded approvals of Moderna's COVID-19 vaccine, a shot for respiratory ...

Even before its $250 million Hazelwood Green facility is finished in 2028, researchers are already making breakthroughs in biomanufacturing.